250 related articles for article (PubMed ID: 24285160)
1. The comparison of thrombocytosis and platelet-lymphocyte ratio as potential prognostic markers in colorectal cancer.
Baranyai Z; Krzystanek M; Jósa V; Dede K; Agoston E; Szász AM; Sinkó D; Szarvas V; Salamon F; Eklund AC; Szállási Z; Jakab F
Thromb Haemost; 2014 Mar; 111(3):483-90. PubMed ID: 24285160
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of thrombocytosis as predictive factor in colorectal cancer].
Baranyai Z; Jósa V; Krzystanek M; Eklund AC; Szász AM; Szállási Z
Magy Seb; 2013 Dec; 66(6):331-7. PubMed ID: 24333978
[TBL] [Abstract][Full Text] [Related]
3. Elevation of platelet count in patients with colorectal cancer predicts tendency to metastases and poor prognosis.
Lin MS; Huang JX; Zhu J; Shen HZ
Hepatogastroenterology; 2012 Sep; 59(118):1687-90. PubMed ID: 22591645
[TBL] [Abstract][Full Text] [Related]
4. Thrombocytosis of Liver Metastasis from Colorectal Cancer as Predictive Factor.
Jósa V; Krzystanek M; Vass T; Lang T; Juhász V; Szilágyi K; Tihanyi B; Harsányi L; Szállási Z; Salamon F; Baranyai Z
Pathol Oncol Res; 2015 Sep; 21(4):991-7. PubMed ID: 25761795
[TBL] [Abstract][Full Text] [Related]
5. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
6. Increased platelet-lymphocyte ratio closely relates to inferior clinical features and worse long-term survival in both resected and metastatic colorectal cancer: an updated systematic review and meta-analysis of 24 studies.
Chen N; Li W; Huang K; Yang W; Huang L; Cong T; Li Q; Qiu M
Oncotarget; 2017 May; 8(19):32356-32369. PubMed ID: 28404961
[TBL] [Abstract][Full Text] [Related]
7. [Preoperative platelet-lymphocyte ratio is an independent prognostic factor for resectable colorectal cancer].
Liu H; DU X; Sun P; Xiao C; Xu Y; Li R
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):70-3. PubMed ID: 23353160
[TBL] [Abstract][Full Text] [Related]
8. Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study.
Chang J; Lin G; Ye M; Tong D; Zhao J; Zhu D; Yu Q; Zhang W; Li W
BMC Cancer; 2019 Jan; 19(1):15. PubMed ID: 30612568
[TBL] [Abstract][Full Text] [Related]
9. Relationship of postoperative thrombocytosis and survival of patients with colorectal cancer.
Josa V; Krzystanek M; Eklund AC; Salamon F; Zarand A; Szallasi Z; Baranyai Z
Int J Surg; 2015 Jun; 18():1-6. PubMed ID: 25843227
[TBL] [Abstract][Full Text] [Related]
10. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with stage III and IV colorectal cancer.
Kim JH; Lee JY; Kim HK; Lee JW; Jung SG; Jung K; Kim SE; Moon W; Park MI; Park SJ
World J Gastroenterol; 2017 Jan; 23(3):505-515. PubMed ID: 28210087
[TBL] [Abstract][Full Text] [Related]
12. Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer.
You J; Zhu GQ; Xie L; Liu WY; Shi L; Wang OC; Huang ZH; Braddock M; Guo GL; Zheng MH
Oncotarget; 2016 May; 7(18):25516-27. PubMed ID: 27027440
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
[TBL] [Abstract][Full Text] [Related]
14. Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer.
Sasaki K; Kawai K; Tsuno NH; Sunami E; Kitayama J
World J Surg; 2012 Jan; 36(1):192-200. PubMed ID: 22045447
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis.
Tan D; Fu Y; Su Q; Wang H
Medicine (Baltimore); 2016 Jun; 95(24):e3837. PubMed ID: 27310960
[TBL] [Abstract][Full Text] [Related]
17. The preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.
Ozawa T; Ishihara S; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Hata K; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Sunami E; Kitayama J; Watanabe T
Int J Colorectal Dis; 2015 Sep; 30(9):1165-71. PubMed ID: 26049902
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.
Kim SH; Lee HW; Go SI; Lee SI; Lee GW
Oncotarget; 2016 Jun; 7(24):36198-36206. PubMed ID: 27105529
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of platelet count in patients with renal cell carcinoma.
Erdemir F; Kilciler M; Bedir S; Ozgok Y; Coban H; Erten K
Urol Int; 2007; 79(2):111-6. PubMed ID: 17851278
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.
Pilati P; Mocellin S; Bertazza L; Galdi F; Briarava M; Mammano E; Tessari E; Zavagno G; Nitti D
Ann Surg Oncol; 2012 Feb; 19(2):402-8. PubMed ID: 22071867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
